These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19109229)

  • 1. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
    Ferre AL; Hunt PW; Critchfield JW; Young DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    Blood; 2009 Apr; 113(17):3978-89. PubMed ID: 19109229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
    Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
    Techakriengkrai N; Tansiri Y; Hansasuta P
    AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
    Shaw JM; Hunt PW; Critchfield JW; McConnell DH; Garcia JC; Pollard RB; Somsouk M; Deeks SG; Shacklett BL
    J Virol; 2011 Nov; 85(21):11422-34. PubMed ID: 21880771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.
    Card CM; Keynan Y; Lajoie J; Bell CP; Dawood M; Becker M; Kasper K; Fowke KR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):427-37. PubMed ID: 22240463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
    Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
    Owen RE; Heitman JW; Hirschkorn DF; Lanteri MC; Biswas HH; Martin JN; Krone MR; Deeks SG; Norris PJ;
    AIDS; 2010 May; 24(8):1095-105. PubMed ID: 20400885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.
    Akinsiku OT; Bansal A; Sabbaj S; Heath SL; Goepfert PA
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):132-40. PubMed ID: 21637109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
    Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
    J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years.
    Peris-Pertusa A; López M; Rallón NI; Restrepo C; Soriano V; Benito JM
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):29-38. PubMed ID: 20634703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
    Critchfield JW; Lemongello D; Walker DH; Garcia JC; Asmuth DM; Pollard RB; Shacklett BL
    J Virol; 2007 Jun; 81(11):5460-71. PubMed ID: 17344302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunity in HIV controllers: the right place at the right time.
    Shacklett BL; Ferre AL
    Curr Opin HIV AIDS; 2011 May; 6(3):202-7. PubMed ID: 21399497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T-cell regeneration in HIV-1 elite controllers.
    Yang Y; Al-Mozaini M; Buzon MJ; Beamon J; Ferrando-Martinez S; Ruiz-Mateos E; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M
    AIDS; 2012 Mar; 26(6):701-6. PubMed ID: 22301416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.